wMerz Therapeutics, a business of the Merz Group and a leader in the field of neurotoxins, and the Israeli start-up Vensica Therapeutics Ltd., a urology company, announced that they have entered into a strategic license and collaboration agreement for the delivery of botulinum neurotoxin A ) to the bladder wall by using Vensica’s innovative ultrasound-assisted delivery catheter.
August 11, 2021
· 6 min read